A groundbreaking study published in The New England Journal of Medicine (NEJM) on Monday demonstrates how specialized devices using artificial intelligence can help restore central vision to treat what was previously a common form of untreatable blindness. This revolutionary technology solution paves the way toward reestablishing sight capabilities for those with vision loss due to geographic atrophy from age-related macular degeneration (AMD).

To achieve this remarkable medical milestone, a global team of researchers led by José-Alain Sahel, M.D., at the University of Pittsburgh School of Medicine, Daniel Palanker, Ph.D., professor of ophthalmology at the Byers Eye Institute at Stanford, and Frank Holz, M.D., at the University of Bonn, created cutting -edge hardware combined wi

See Full Page